Abstract
Preeclampsia (PE) is a gestational disorder and genetic and epigenetic alterations can affect its pathogenesis. Some evidences showed that the altered expression of miRNAs in the placentas complicated by PE. The blood samples from 219 PE and 242 normotensive pregnant women and placental tissue samples from 111 PE and 119 normotensive women were collected. MiR-146a and miR-149 polymorphisms were genotyped in blood samples and placentas using PCR–RFLP method. The frequencies of maternal miR-146a rs2910164 GC and CC genotypes did not differ between PE and control groups. However, the miR-146a rs2910164 G/C polymorphism was associated with an increased risk of PE in dominant (OR 1.5, 95% CI 1–2.1; P = 0.04) and allelic (OR 1.4, 95% CI 1–1.9; P = 0.04) but not recessive models. Moreover, the maternal GC and CC genotypes were associated with a 1.9- and 3.4-fold increased risk of severe PE (OR 1.9, 95% CI 1.1–3.2; P = 0.02 and OR 3.4, 95% CI 1.3–9; P = 0.01, respectively) and miR-146a rs2910164 polymorphism could increase risk of severe PE in dominant and recessive models (OR 2.1, 95% CI 1.3–3.4; P = 0.004 and OR 2.6, 95% CI 1–6.7; P = 0.04). The placental miR-146a rs2910164 polymorphism was associated with PE susceptibility in dominant (OR 1.8, 95% CI 1.1–3; P = 0.03) and allelic models (OR 1.7, 95% CI 1.1–2.5; P = 0.02). The frequencies of maternal and placental miR-149 rs2292832 genotypes were not different between two groups and these genotypes were not associated with PE or severe PE risk. In conclusion, according to logistic regression analysis the maternal/placental miR-146a rs2910164 G/C polymorphism was associated with PE and/or severe PE risk.
Similar content being viewed by others
References
Jeyabalan A (2013) Epidemiology of preeclampsia: impact of obesity. Nutr Rev 71(Suppl 1):S18–S25. https://doi.org/10.1111/nure.12055
Kharaghani R, Cheraghi Z, Okhovat Esfahani B, Mohammadian Z, Nooreldinc RS (2016) Prevalence of preeclampsia and eclampsia in Iran. Arch Iran Med 19(1):64–71
Choudhury M, Friedman JE (2012) Epigenetics and microRNAs in preeclampsia. Clin Exp Hypertens 34(5):334–341. https://doi.org/10.3109/10641963.2011.649931
Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW (2001) Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344(12):867–872. https://doi.org/10.1056/NEJM200103223441201
Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT (2005) Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 331(7521):877. https://doi.org/10.1136/bmj.38555.462685.8F
Roberts JM, Gammill HS (2005) Preeclampsia: recent insights. Hypertension 46(6):1243–1249. https://doi.org/10.1161/01.HYP.0000188408.49896.c5
Powe CE, Levine RJ, Karumanchi SA (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123(24):2856–2869. https://doi.org/10.1161/CIRCULATIONAHA.109.853127
Roberts JM, Escudero C (2012) The placenta in preeclampsia. Pregnancy Hypertens 2(2):72–83. https://doi.org/10.1016/j.preghy.2012.01.001
Williams PJ, Broughton Pipkin F (2011) The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 25(4):405–417. https://doi.org/10.1016/j.bpobgyn.2011.02.007
Peixoto AB, Rolo LC, Nardozza LMM, Araujo Junior E (2018) Epigenetics and preeclampsia: programming of future outcomes. Methods Mol Biol 1710:73–83. https://doi.org/10.1007/978-1-4939-7498-6_6
Mohammadpour-Gharehbagh A, Teimoori B, Narooei-Nejad M, Mehrabani M, Saravani R, Salimi S (2017) The association of the placental MTHFR 3′-UTR polymorphisms, promoter methylation, and MTHFR expression with preeclampsia. J Cell Biochem. https://doi.org/10.1002/jcb.26290
Keshavarzi F, Mohammadpour-Gharehbagh A, Shahrakipour M, Teimoori B, Yazdi A, Yaghmaei M, Naroeei-Nejad M, Salimi S (2017) The placental vascular endothelial growth factor polymorphisms and preeclampsia/preeclampsia severity. Clin Exp Hypertens 39(7):606–611. https://doi.org/10.1080/10641963.2017.1299751
Bounds KR, Chiasson VL, Pan LJ, Gupta S, Chatterjee P (2017) MicroRNAs: new players in the pathobiology of preeclampsia. Front Cardiovasc Med 4:60. https://doi.org/10.3389/fcvm.2017.00060
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Lv Y, Lu C, Ji X, Miao Z, Long W, Ding H, Lv M (2019) Roles of microRNAs in Preeclampsia. J Cell Physiol 234(2):1052–1061. https://doi.org/10.1002/jcp.27291
Li CX, Weng H, Zheng J, Feng ZH, Ou JL, Liao WJ (2018) Association between MicroRNAs polymorphisms and risk of ischemic stroke: a meta-analysis in Chinese individuals. Front Aging Neurosci 10:82. https://doi.org/10.3389/fnagi.2018.00082
Eskandari F, Rezaei M, Mohammadpour-Gharehbagh A, Teimoori B, Yaghmaei M, Narooei-Nejad M, Salimi S (2018) The association of pri-miRNA-26a1 rs7372209 polymorphism and preeclampsia susceptibility. Clin Exp Hypertens. https://doi.org/10.1080/10641963.2018.1469643
Ryan BM, Robles AI, Harris CC (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10(6):389–402. https://doi.org/10.1038/nrc2867
Zeng J, Yi X, Liu H, Yang Y, Duan Y, Chen H (2018) Polymorphisms in four microRNAs and risk of oral squamous cell cancer: a meta-analysis. Oncotarget 9(9):8695–8705. https://doi.org/10.18632/oncotarget.24211
Sung JH, Kim SH, Yang WI, Kim WJ, Moon JY, Kim IJ, Cha DH, Cho SY, Kim JO, Kim KA, Kim OJ, Lim SW, Kim NK (2016) miRNA polymorphisms (miR146a, miR149, miR196a2 and miR499) are associated with the risk of coronary artery disease. Mol Med Rep 14(3):2328–2342. https://doi.org/10.3892/mmr.2016.5495
Xiong XD, Cho M, Cai XP, Cheng J, Jing X, Cen JM, Liu X, Yang XL, Suh Y (2014) A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat Res 761:15–20. https://doi.org/10.1016/j.mrfmmm.2014.01.001
Xie YF, Shu R, Jiang SY, Liu DL, Ni J, Zhang XL (2013) MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts. J Inflamm 10(1):20. https://doi.org/10.1186/1476-9255-10-20
Zhang X, Gu Y, Liu X, Yu Y, Shi J, Yu Q, Sun H, Kanu JS, Zhan S, Liu Y (2015) Association of pre-miR-146a rs2910164 polymorphism with papillary thyroid cancer. Int J Endocrinol 2015:802562. https://doi.org/10.1155/2015/802562
Alipoor B, Meshkani R, Ghaedi H, Sharifi Z, Panahi G, Golmohammadi T (2016) Association of miR-146a rs2910164 and miR-149 rs2292832 variants with susceptibility to type 2 diabetes. Clin Lab 62(8):1553–1561. https://doi.org/10.7754/Clin.Lab.2016.160124
Zou D, Liu C, Zhang Q, Li X, Qin G, Huang Q, Meng Y, Chen L, Wei J (2018) Association between polymorphisms in microRNAs and ischemic stroke in an Asian population: evidence based on 6,083 cases and 7,248 controls. Clin Interv Aging 13:1709–1726. https://doi.org/10.2147/CIA.S174000
Maharaj NR, Ramkaran P, Pillay S, Chuturgoon AA (2017) MicroRNA-146a rs2910164 is associated with severe preeclampsia in Black South African women on HAART. BMC Genet 18(1):5. https://doi.org/10.1186/s12863-016-0469-z
Abo-Elmatty DM, Mehanna ET (2018) MIR146A rs2910164 (G/C) polymorphism is associated with incidence of preeclampsia in gestational diabetes patients. Biochem Genet. https://doi.org/10.1007/s10528-018-9886-1
American College of O, Gynecologists, Task Force on Hypertension in P (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122(5):1122–1131. https://doi.org/10.1097/01.aog.0000437382.03963.88
Mohammadpour-Gharehbagh A, Teimoori B, Narooei-Nejad M, Mehrabani M, Saravani R, Salimi S (2018) The association of the placental MTHFR 3’-UTR polymorphisms, promoter methylation, and MTHFR expression with preeclampsia. J Cell Biochem 119(2):1346–1354. https://doi.org/10.1002/jcb.26290
Yan P, Xia M, Gao F, Tang G, Zeng H, Yang S, Zhou H, Ding D, Gong L (2015) Predictive role of miR-146a rs2910164 (C > G), miR-149 rs2292832 (T > C), miR-196a2 rs11614913 (T > C) and miR-499 rs3746444 (T > C) in the development of hepatocellular carcinoma. Int J Clin Exp Pathol 8(11):15177–15183
Tannetta D, Sargent I (2013) Placental disease and the maternal syndrome of preeclampsia: missing links? Curr Hypertens Rep 15(6):590–599. https://doi.org/10.1007/s11906-013-0395-7
Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N (2011) Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci 18(1):46–56. https://doi.org/10.1177/1933719110374115
Fu G, Brkic J, Hayder H, Peng C (2013) MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci 14(3):5519–5544. https://doi.org/10.3390/ijms14035519
Hayder H, O’Brien J, Nadeem U, Peng C (2018) MicroRNAs: crucial regulators of placental development. Reproduction 155(6):R259–R271. https://doi.org/10.1530/REP-17-0603
Tahamtan A, Teymoori-Rad M, Nakstad B, Salimi V (2018) Anti-inflammatory MicroRNAs and their potential for inflammatory diseases treatment. Front Immunol 9:1377. https://doi.org/10.3389/fimmu.2018.01377
Zhong X, Jiang YZ, Liu P, He W, Xiong Z, Chang W, Zhu J, Cui Q (2016) Toll-like 4 receptor/NFkappaB inflammatory/miR-146a pathway contributes to the ART-correlated preterm birth outcome. Oncotarget 7(45):72475–72485. https://doi.org/10.18632/oncotarget.11987
Dai Y, Jia P, Fang Y, Liu H, Jiao X, He JC, Ding X (2016) miR-146a is essential for lipopolysaccharide (LPS)-induced cross-tolerance against kidney ischemia/reperfusion injury in mice. Sci Rep 6:27091. https://doi.org/10.1038/srep27091
Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, Sliwa K, Noel A, Martial JA, Hilfiker-Kleiner D, Struman I (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Investig 123(5):2143–2154. https://doi.org/10.1172/JCI64365
Testa U, Pelosi E, Castelli G, Labbaye C (2017) miR-146 and miR-155: two key modulators of immune response and tumor development. Non-coding RNA 3(3):1. https://doi.org/10.3390/ncrna3030022
Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, Sun G, Tay J, Linsley PS, Baltimore D (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208(6):1189–1201. https://doi.org/10.1084/jem.20101823
Campos CB, Marques TM, Pereira RW, Sandrim VC (2014) Reduced circulating miR-196b levels is associated with preeclampsia. Pregnancy Hypertens 4(1):11–13. https://doi.org/10.1016/j.preghy.2013.10.002
Hromadnikova I, Kotlabova K, Hympanova L, Krofta L (2016) Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood. Thromb Res 137:126–140. https://doi.org/10.1016/j.thromres.2015.11.032
Dayan N, Schlosser K, Stewart DJ, Delles C, Kaur A, Pilote L (2018) Circulating MicroRNAs implicate multiple atherogenic abnormalities in the long-term cardiovascular sequelae of Preeclampsia. Am J Hypertens 31(10):1093–1097. https://doi.org/10.1093/ajh/hpy069
Jeon YJ, Kim SY, Rah H, Choi DH, Cha SH, Yoon TK, Lee WS, Shim SH, Kim NK (2012) Association of the miR-146aC > G, miR-149T > C, miR-196a2T > C, and miR-499A > G polymorphisms with risk of spontaneously aborted fetuses. Am J Reprod Immunol 68(5):408–417. https://doi.org/10.1111/aji.12005
He Y, Yu D, Zhu L, Zhong S, Zhao J, Tang J (2018) miR-149 in human cancer: a systemic review. J Cancer 9(2):375–388. https://doi.org/10.7150/jca.21044
Holtan SG, Creedon DJ, Haluska P, Markovic SN (2009) Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 84(11):985–1000. https://doi.org/10.1016/S0025-6196(11)60669-1
Guo L, Tsai SQ, Hardison NE, James AH, Motsinger-Reif AA, Thames B, Stone EA, Deng C, Piedrahita JA (2013) Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas. Placenta 34(7):599–605. https://doi.org/10.1016/j.placenta.2013.04.007
Yang S, Li H, Ge Q, Guo L, Chen F (2015) Deregulated microRNA species in the plasma and placenta of patients with preeclampsia. Mol Med Rep 12(1):527–534. https://doi.org/10.3892/mmr.2015.3414
Xiaobo Z, Qizhi H, Zhiping W, Tao D (2019) Down-regulated miR-149-5p contributes to preeclampsia via modulating endoglin expression. Pregnancy Hypertens 15:201–208. https://doi.org/10.1016/j.preghy.2019.01.002
Funding
The study was funded by Zahedan University of Medical Sciences (No 7871).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical statement
This study was approved by the ethics committee of Zahedan University of Medical Sciences (IR. ZAUMS. REC.1395.76).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Salimi, S., Eskandari, F., Rezaei, M. et al. The effect of miR-146a rs2910164 and miR-149 rs2292832 polymorphisms on preeclampsia susceptibility. Mol Biol Rep 46, 4529–4536 (2019). https://doi.org/10.1007/s11033-019-04908-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-019-04908-2